These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8868290)

  • 1. Specific in vivo binding in the rat brain of [18F]RP 62203: a selective 5-HT2A receptor radioligand for positron emission tomography.
    Besret L; Dauphin F; Huard C; Lasne MC; Vivet R; Mickala P; Barbelivien A; Baron JC
    Nucl Med Biol; 1996 Feb; 23(2):169-71. PubMed ID: 8868290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of central 5-HT2A receptor radioligands for PET: comparison of [3H]RP 62203 and [3H]SR 46349B kinetics in rat brain.
    Ashworth S; Hume SP; Lammertsma AA; Opacka-Juffry J; Shah F; Pike VW
    Nucl Med Biol; 1996 Apr; 23(3):245-50. PubMed ID: 8782232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [carbonyl-11C]Desmethyl-WAY-100635 (DWAY) is a potent and selective radioligand for central 5-HT1A receptors in vitro and in vivo.
    Pike VW; Halldin C; McCarron JA; Lundkvist C; Hirani E; Olsson H; Hume SP; Karlsson P; Osman S; Swahn CG; Hall H; Wikström H; Mensonidas M; Poole KG; Farde L
    Eur J Nucl Med; 1998 Apr; 25(4):338-46. PubMed ID: 9553162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Test-retest variability of serotonin 5-HT2A receptor binding measured with positron emission tomography and [18F]altanserin in the human brain.
    Smith GS; Price JC; Lopresti BJ; Huang Y; Simpson N; Holt D; Mason NS; Meltzer CC; Sweet RA; Nichols T; Sashin D; Mathis CA
    Synapse; 1998 Dec; 30(4):380-92. PubMed ID: 9826230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoradiographic studies of RP 62203, a potent 5-HT2 receptor antagonist. Pharmacological characterization of [3H]RP 62203 binding in the rat brain.
    Malgouris C; Flamand F; Doble A
    Eur J Pharmacol; 1993 Mar; 233(1):37-45. PubMed ID: 8472747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [11C]MDL 100907, a radioligland for selective imaging of 5-HT(2A) receptors with positron emission tomography.
    Lundkvist C; Halldin C; Ginovart N; Nyberg S; Swahn CG; Carr AA; Brunner F; Farde L
    Life Sci; 1996; 58(10):PL 187-92. PubMed ID: 8602111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo regulation of serotonin 5-HT2A receptors in rat brain by subchronic administration of sigma receptor ligand NE-100.
    Hashimoto K; Narita N; Tomitaka S; Iyo M; Minabe Y
    Life Sci; 1997; 60(24):2245-54. PubMed ID: 9188767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [3H]RP 62203, a ligand of choice to label in vivo brain 5-HT2 receptors.
    Fajolles C; Boireau A; Ponchant M; Laduron PM
    Eur J Pharmacol; 1992 May; 216(1):53-7. PubMed ID: 1526254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective visualization of rat brain 5-HT2A receptors by autoradiography with [3H]MDL 100,907.
    López-Giménez JF; Mengod G; Palacios JM; Vilaró MT
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Oct; 356(4):446-54. PubMed ID: 9349630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A method for the in vivo investigation of the serotonergic 5-HT2 receptors in the human cerebral cortex using positron emission tomography and 18F-labeled setoperone.
    Blin J; Sette G; Fiorelli M; Bletry O; Elghozi JL; Crouzel C; Baron JC
    J Neurochem; 1990 May; 54(5):1744-54. PubMed ID: 2182776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [3H]MDL 100,907 labels 5-HT2A serotonin receptors selectively in primate brain.
    López-Giménez JF; Vilaró MT; Palacios JM; Mengod G
    Neuropharmacology; 1998 Sep; 37(9):1147-58. PubMed ID: 9833645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visualisation of loss of 5-HT2A receptors with age in healthy volunteers using [18F]altanserin and positron emission tomographic imaging.
    Rosier A; Dupont P; Peuskens J; Bormans G; Vandenberghe R; Maes M; de Groot T; Schiepers C; Verbruggen A; Mortelmans L
    Psychiatry Res; 1996 Nov; 68(1):11-22. PubMed ID: 9027929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical evaluation of [123I]R93274 as a SPECT radiotracer for imaging 5-HT2A receptors.
    Abi-Dargham A; Zea-Ponce Y; Terriere D; al-Tikriti M; Baldwin RM; Hoffer P; Charney D; Leysen JE; Laruelle M; Mertens J; Innis RB
    Eur J Pharmacol; 1997 Mar; 321(3):285-93. PubMed ID: 9085039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of radioactive metabolites of 5-HT2A receptor PET ligand [18F]altanserin in human and rodent.
    Tan PZ; Baldwin RM; Van Dyck CH; Al-Tikriti M; Roth B; Khan N; Charney DS; Innis RB
    Nucl Med Biol; 1999 Aug; 26(6):601-8. PubMed ID: 10587097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-steady-state measurement of in vivo radioligand binding with positron emission tomography: specificity analysis and comparison with in vitro binding.
    Perlmutter JS; Moerlein SM; Hwang DR; Todd RD
    J Neurosci; 1991 May; 11(5):1381-9. PubMed ID: 1827499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomographic analysis of dose-dependent MDL 100,907 binding to 5-hydroxytryptamine-2A receptors in the human brain.
    Andrée B; Nyberg S; Ito H; Ginovart N; Brunner F; Jaquet F; Halldin C; Farde L
    J Clin Psychopharmacol; 1998 Aug; 18(4):317-23. PubMed ID: 9690698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 123I-MSP and F[11C]MSP: new selective 5-HT2A receptor radiopharmaceuticals for in vivo studies of neuronal 5-HT2 serotonin receptors. Synthesis, in vitro binding study with unlabelled analogues and preliminary in vivo evaluation in mice.
    Samnick S; Remy N; Ametamey S; Bader JB; Brandau W; Kirsch CM
    Life Sci; 1998; 63(22):2001-13. PubMed ID: 9839544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.
    Leysen JE; Gommeren W; Van Gompel P; Wynants J; Janssen PF; Laduron PM
    Mol Pharmacol; 1985 Jun; 27(6):600-11. PubMed ID: 2860558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical evaluation of [18F]2FNQ1P as the first fluorinated serotonin 5-HT6 radioligand for PET imaging.
    Becker G; Colomb J; Sgambato-Faure V; Tremblay L; Billard T; Zimmer L
    Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):495-502. PubMed ID: 25331460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [18F]fluoroalkyl analogues of the potent 5-HT1A antagonist WAY 100635: radiosyntheses and in vivo evaluation.
    Wilson AA; DaSilva JN; Houle S
    Nucl Med Biol; 1996 May; 23(4):487-90. PubMed ID: 8832704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.